Page last updated: 2024-10-22

2-aminothiazole and Acute Confusional Senile Dementia

2-aminothiazole has been researched along with Acute Confusional Senile Dementia in 5 studies

2-aminothiazole: RN given refers to parent cpd; structure
1,3-thiazol-2-amine : A primary amino compound that is 1,3-thiazole substituted by an amino group at position 2.

Research

Studies (5)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (20.00)29.6817
2010's1 (20.00)24.3611
2020's3 (60.00)2.80

Authors

AuthorsStudies
Kilic, B2
Bardakkaya, M2
Ilıkcı Sagkan, R1
Aksakal, F2
Shakila, S2
Dogruer, DS2
Sagkan, RI1
Huffman, SE1
Yawson, GK1
Fisher, SS1
Bothwell, PJ1
Platt, DC1
Jones, MA1
Hamaker, CG1
Webb, MI1
Lagoja, I1
Pannecouque, C1
Griffioen, G1
Wera, S1
Rojasdelaparra, VM1
Van Aerschot, A1
Helal, CJ1
Sanner, MA1
Cooper, CB1
Gant, T1
Adam, M1
Lucas, JC1
Kang, Z1
Kupchinsky, S1
Ahlijanian, MK1
Tate, B1
Menniti, FS1
Kelly, K1
Peterson, M1

Other Studies

5 other studies available for 2-aminothiazole and Acute Confusional Senile Dementia

ArticleYear
New thiourea and benzamide derivatives of 2-aminothiazole as multi-target agents against Alzheimer's disease: Design, synthesis, and biological evaluation.
    Bioorganic chemistry, 2023, Volume: 131

    Topics: Acetylcholinesterase; Alzheimer Disease; Benzamides; Butyrylcholinesterase; Cholinesterase Inhibitor

2023
Synthesis and evaluation of multitarget new 2-aminothiazole derivatives as potential anti-Alzheimer's agents.
    Archiv der Pharmazie, 2023, Volume: 356, Issue:8

    Topics: Acetylcholinesterase; Alzheimer Disease; Butyrylcholinesterase; Cholinesterase Inhibitors; Humans; M

2023
Ruthenium(iii) complexes containing thiazole-based ligands that modulate amyloid-β aggregation.
    Metallomics : integrated biometal science, 2020, 04-01, Volume: 12, Issue:4

    Topics: Alzheimer Disease; Amyloid beta-Peptides; Animals; Cell Line, Tumor; Cell Survival; Coordination Com

2020
Substituted 2-aminothiazoles are exceptional inhibitors of neuronal degeneration in tau-driven models of Alzheimer's disease.
    European journal of pharmaceutical sciences : official journal of the European Federation for Pharmaceutical Sciences, 2011, Aug-17, Volume: 43, Issue:5

    Topics: Alzheimer Disease; Cell Line; Humans; Magnetic Resonance Spectroscopy; Mass Spectrometry; Models, Bi

2011
Discovery and SAR of 2-aminothiazole inhibitors of cyclin-dependent kinase 5/p25 as a potential treatment for Alzheimer's disease.
    Bioorganic & medicinal chemistry letters, 2004, Nov-15, Volume: 14, Issue:22

    Topics: Alzheimer Disease; Amides; CDC2-CDC28 Kinases; Cyclin-Dependent Kinase 2; Cyclin-Dependent Kinase 5;

2004